Preparation of l-Nα-Fmoc-4-[di-(tert-butyl)phosphonomethyl]phenylalanine from l-tyrosine

Burke Jr., T. R.; Yao, Z.-J.; Smyth, M. S.; Ye, B. Curr. Pharm. Des. 1997, 3, 291–304. Domchek, S. M.; Auger, K. R.; Chatterjee, S.; Burke, T. R.; Shoelson, S. E. Biochemistry 1992, 31, 9865–9870. Yao, Z.-J.; King, C. R.; Cao, T.; Kelley, J.; Milne, G. W. A.; Voigt, J. H.; Burke Jr., T. R. J. Med. Chem. 1999, 42, 25–35. Schoepfer, J.; Fretz, H.; Gay, B.; Furet, P.; GarciaEcheverria, C.; End, N.; Caravatti, G. Bioorg. Med. Chem. Lett. 1999, 9, 221–226. Marseigne, I.; Roques, B. P. J. Org. Chem. 1988, 53, 3621–3624. Garbay-Jaureguiberry, C.; McCort-Tranchepain, I.; Barbe, B.; Ficheux, D.; Roques, B. P. Tetrahedron: Asymmetry 1992, 3, 637–650. Cushman, M.; Lee, E. S. Tetrahedron Lett. 1992, 33, 1193–1196. Dow, R. L.; Bechle, B. M. Synlett. 1994, 293–294. Burke Jr., T. R.; Russ, P.; Lim, B. Synthesis 1991, 11, 1019–1020. Josien, H.; Matin, A.; Chassaing, G. Tetrahedron Lett. 1991, 32, 6547–6550. Liu, W. Q.; Roques, B. P.; Garbay-Jaureguiberry, C. Tetrahedron: Asymmetry 1995, 6, 647–650. Hartman, G. D.; Halczenko, H. Synth. Commun. 1991, 21, 2103–2107. Yokomatsu, T.; Yamagishi, T.; Matsumoto, K.; Shibuya, S. Tetrahedron 1996, 52, 11725–11738. Rasmussen, J. R.; Slinger, C. J.; Kordish, R. J.; Newman-Evans, D. D. J. Org. Chem. 1981, 46, 4843–4846. Baczko, K.; Liu, W. Q.; Roques, B. P.; GarbayJaureguiberry, C. Tetrahedron 1996, 52, 2021–2030. Whole animal studies with Pmp-containing Grb2 SH2 domain inhibitor 4 are currently in progress. Rink, H. Tetrahedron Lett. 1987, 28, 3787–3790. Burke, T. R.; Yao, Z. J.; Zhao, H.; Milne, G. W. A.; Wu, L.; Zhang, Z. Y.; Voigt, J. H. Tetrahedron 1998, 54, 9981–9994.